Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported. We here assessed the effect of ivermectin in Syrian hamsters infected with the SARS-CoV-2 Beta (B.1.351) variant. Infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Foo, Caroline S., Abdelnabi, Rana, Vangeel, Laura, De Jonghe, Steven, Jochmans, Dirk, Weynand, Birgit, Neyts, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955654/
https://www.ncbi.nlm.nih.gov/pubmed/35336208
http://dx.doi.org/10.3390/microorganisms10030633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955654/
https://www.ncbi.nlm.nih.gov/pubmed/35336208
http://dx.doi.org/10.3390/microorganisms10030633

Ejemplares similares